|.::

Health News

Beximco Pharma rejects allegations of corruption

Beximco Pharmaceuticals Ltd. (Beximco Pharma) is deeply concerned and disappointed by the misleading and defamatory news published on March 17 and 18, 2025 in several news portals, dailies and TV channels. These reports alleged Company involvement in the corruption during the procurement of Covid-19 vaccines. The Company rejects these baseless allegations and protests the sensationalized and slanderous headlines, that not only tarnished corporate reputation as a globally known pharmaceutical manufacturer and exporter but also confused thousands of its valued shareholders, especially many foreign investors who currently hold more than 32% of company shares.
Beximco Pharma was involved with the procurement of 15 million (1.5 crore) doses of Oxford/AstraZeneca vaccine (Covishield) from Serum Institute of India (SII), the world largest vaccine producer, costing USD 60 million (BDT 480 crore) and Beximco Pharma received USD 1 (one) per dose totaling USD 15 million (BDT 120 crore) for supplying the same. Thus, the total cost incurred for 15 million Covishield doses stood at BDT 600 crore while several media and news portals clearly attempted to malign Beximco Pharma with headlines saying the company is being investigated for BDT 22,000 crore corruption in connection to Covid-19 vaccine purchase.
The reports claimed that The Anti-Corruption Commission (ACC) has decided to launch an inquiry against a syndicate involving Salman F Rahman, Beximco Pharma and others over alleged embezzlement of BDT 22,000 crore government funds during the Covid-19 vaccine procurement process. It further alleged that the government bypassed competitive bidding and negotiations by pursuing a single source for vaccine procurement.

Survival of one lowest birth weight premature Baby at Evercare

Evercare Hospital Dhaka (EHD), the country first JCI-accredited hospital, arranged a press meet to announce the successful survival of one of the lowest birth weight premature babies to be born in Evercare Hospital Dhaka. The infant, born at just 25 weeks and 4 days gestation with a birth weight of 550 grams, has been discharged from the hospital after a remarkable 3 months and 26 days stay in the Neonatal Unit.
The baby was delivered by Dr. Nasrin Zulfiqar, an obstetrician at Evercare Hospital, through a caesarian section after the mother developed pre-eclampsia, and there was compromised fetus blood flow. The decision to deliver the baby was critical, as both the mother and the baby were at high risk of death if the pregnancy would have been continued. Following birth, the baby was admitted to the Neonatal Unit, where the baby received continuous care under the supervision of Dr. Abu Sayeed Mohammad Iqbal, Senior Consultant, Pediatrics & Neonatology, and Neonatal Intensivist.
Given the extreme prematurity of the baby, intensive neonatal support was required, including incubator care, ventilator life support, proper nutrition, electrolyte management, infection control, and round-the-clock nursing care.
"We are immensely grateful to the baby parents for their unwavering patience, cooperation, and support throughout this challenging journey. We also extend our heartfelt thanks to the entire neonatal team and all supporting departments at Evercare Hospital Dhaka for their dedicated efforts in ensuring the baby survival. The Neonatology team at Evercare Hospital Dhaka is committed to providing world-class care for premature babies." said Dr. Abu Sayeed Mohammad Iqbal.
Dr. Arif Mahmud, Group Medical Director of Evercare Hospitals, Bangladesh said, “I would like to express my gratitude and appreciation to the whole Neonatology team, specially to Dr. Abu Sayeed Mohammad Iqbal and Dr. Nusrat Farooq for their excellent hard work. This is one of the milestones of the hospital. It indicates our commitment and dedication for the safety of the patients of Bangladesh.”
The press meet was graced by Evercare Hospital Dhaka Dr. Abu Sayeed Mohammad Iqbal, Senior Consultant, Pediatrics & Neonatology, and Neonatal Intensivist; Dr. Nusrat Farooq, Senior Consultant, Pediatrics & Neonatology, and Neonatal Intensivist; Dr. Monowara Begum, Senior Consultant of Obstetrics & Gynaecology; and Dr. Arif Mahmud, Group Medical Director of Evercare Hospitals, Bangladesh and other consultants.

Scientific discussion on transforming Bone Marrow held

Evercare Hospital Dhaka recently organized a Scientific Discussion Session on Transforming Bone Marrow Transplantation and Hematology in Bangladesh and a rally, where nurses and doctors came together, carrying banners and placards, and distributed leaflets to raise awareness about blood disorders.
At the same time the its Hematology and Bone Marrow Transplant (BMT) Unit celebrates it’s decade of excellence in Blood Cancer Management since the department’s inception on November 1, 2014.
Dr. Abu Jafar Mohammed Saleh, Senior Consultant and Co-Ordinator of the Hematology and Bone Marrow Transplant (BMT) Unit of Evercare Hospitals, Bangladesh (Dhaka & Chattogram), said, “Everyone needs to be more aware of combating deadly diseases like blood cancer and should be proactive in seeking timely treatment. Our goal is to provide excellent patient care, at a competitive price.”
Dr. Ratnadeep Chaskar, MD & CEO of Evercare Hospitals, Bangladesh said, “Our Hematology and BMT department has significantly improved patient care in Bangladesh. We remain steadfast in our mission to provide innovative treatments and hope for our patients.”
Dr. Arif Mahmud, Group Medical Director of Evercare Hospitals, Bangladesh said, “Over the past decade, our Hematology and BMT department has been committed to transforming lives through advanced treatment and compassionate care. As we mark this milestone, we look forward to enhancing excellence and hope in patient care."

Breast Cancer Awareness Day observed

Evercare Hospital, the first JCI-accredited hospital in Bangladesh, hosted a significant patient forum for Breast Cancer Awareness. The forum featured Evercare Hospital Dhaka oncologists, surgeons, and specialists, highlighting the life-savingimpact of early detection and timely treatment. With breast cancer being the most common cancer among women in Bangladesh, accounting for 19% of female cancers, experts emphasized that early diagnosis can improve survival rates by up to 90%.
The patient forum featured keyinsights from Dr. Ratnadeep Chaskar, CEO & MD of Evercare Hospitals, Bangladesh, and Dr. Arif Mahmud, Group Medical Director of Evercare Hospitals, Bangladesh as they set the stage for a discussion that touched hearts andminds.
Their message was that early diagnosis can save lives, and Evercare Hospital Dhaka stands at the forefront of delivering world-class care to breast cancer patients in Bangladesh. Adding to the discourse Dr. Ferdous Shahriar Sayed, Senior Consultant & Coordinator, Medical Oncology; Dr.Biswajit Bhattacharjee, Senior Consultant of Clinical Oncology &Coordinator of Radiation Oncology; Dr. Raju Titus Chako, Senior Consultant, Medical Oncology, and Dr. Arman Reza Chowdhury, Senior Consultant, Radiation Oncology, discussed the importance of integrated treatment approaches. Their combined expertise showcased how far cancer care has evolved in providing hopefor patients.
The forum highlighted key awareness topics, including understanding risk factors like age, genetics, and lifestylechoices, as well as the benefits of regular screenings through